4.7 Article

Revisiting the combinatorial potential of cytokine subunits in the IL-12 family

Journal

BIOCHEMICAL PHARMACOLOGY
Volume 165, Issue -, Pages 240-248

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2019.03.026

Keywords

Cytokines; Inflammation; Interleukin; Heterodimer; IL-12 family

Funding

  1. Flanders Agency for Innovation and Entrepreneurship (VLAIO-Flanders, Belgium)
  2. Research Foundation Flanders (FWO, Belgium)
  3. Research Foundation Flanders (FWO, Belgium) [GOE1516N, G0B4918N]
  4. Hercules Foundation (Belgium) [AUGE-11-029]
  5. VIB

Ask authors/readers for more resources

The four core members of the Interleukin-12 (IL-12) family of cytokines, IL-12, IL-23, IL-27 and IL-35 are heterodimers which share alpha- and beta-cytokine subunits. All four cytokines are immune modulators and have been proposed to play divergent roles in inflammatory arthritis. In recent years additional combinations of alpha- and beta-cytokine subunits belonging to the IL-12 family have been proposed to form novel cytokines such as IL-39. However, the actual extent of the combinatorial potential of the cytokine subunits in the human IL-12 family is not known. Here, we identify several combinations of subunits that form secreted heterodimeric assemblies based on a systematic orthogonal approach. The heterodimers are detected in the conditioned media harvested from mammalian cell cultures transfected with unfused pairs of cytokine subunits. While certain previously reported subunit combinations could not be recapitulated, our approach showed robustly that all four of the canonical members could be secreted. Furthermore, we provide evidence for the interaction between Cytokine Receptor Like Factor 1 (CRLF1) and Interleukin-12 subunit alpha (p35). Similar to IL-27 and IL-35 this novel heterodimer is not abundantly secreted rendering isolation from the conditioned medium very challenging, unlike IL-12 and IL-23. Our findings set the stage for fine-tuning approaches towards the biochemical reconstitution of IL-12 family cytokines for biochemical, cellular, and structural studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

Engineering and crystal structure of a monomeric FLT3 ligand variant

Erwin Pannecoucke, Laurens Raes, Savvas N. Savvides

Summary: The study found that the hematopoietic receptor FLT3 is activated by dimerization with a monomeric cytokine FL (FLL27D), rather than through receptor-receptor contacts.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2021)

Review Pharmacology & Pharmacy

Natural Antibodies: Protecting Role of IgM in Glioblastoma and Brain Tu-mours

Shubham Semwal, Rabah Boukherroub, Savvas N. Savvides, Julie Bouckaert

Summary: Glioblastoma is a deadly brain tumor with limited treatment options, requiring novel approaches to be explored. Immunoglobulin-M may play a significant role in glioblastoma and could potentially offer new treatment possibilities.

CURRENT PHARMACEUTICAL DESIGN (2021)

Review Pharmacology & Pharmacy

Rational Design and Development of HDAC Inhibitors for Breast Cancer Treatment

Deepansh Mody, Julie Bouckaert, Savvas N. Savvides, Vibha Gupta

Summary: Research on the differential expression of HDAC isoforms in different types of breast cancer cells may lead to the discovery of selective HDAC inhibitors for personalized treatment.

CURRENT PHARMACEUTICAL DESIGN (2021)

Editorial Material Biochemistry & Molecular Biology

Acetyl-CoA is produced by the citrate synthase homology module of ATP-citrate lyase

Kenneth Verstraete, Koen H. G. Verschueren, Ann Dansercoer, Savvas N. Savvides

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)

Article Multidisciplinary Sciences

Distinct EH domains of the endocytic TPLATE complex confer lipid and protein binding

Klaas Yperman, Anna C. Papageorgiou, Romain Merceron, Steven De Munck, Yehudi Bloch, Dominique Eeckhout, Qihang Jiang, Pieter Tack, Rosa Grigoryan, Thomas Evangelidis, Jelle Van Leene, Laszlo Vincze, Peter Vandenabeele, Frank Vanhaecke, Martin Potocky, Geert De Jaeger, Savvas N. Savvides, Konstantinos Tripsianes, Roman Pleskot, Daniel Van Damme

Summary: This study elucidated the structural and functional roles of the EH domains of the TPC subunit AtEH1/Pan1 in plant Clathrin-mediated endocytosis (CME). The research integrated high-resolution structural information obtained by X-ray crystallography and NMR spectroscopy with all-atom molecular dynamics simulations to provide insights into the function of both EH domains. The study revealed distinct but complementary roles of the EH domains of AtEH/Pan1 in plant CME and connected the internalization of SCAMP5 to the TPLATE complex.

NATURE COMMUNICATIONS (2021)

Review Immunology

Charcot-Leyden crystals and other protein crystals driving type 2 immunity and allergy

Helena Aegerter, Ursula Smole, Ines Heyndrickx, Kenneth Verstraete, Savvas N. Savvides, Hamida Hammad, Bart N. Lambrecht

Summary: Protein crystals derived from innate immune cells have been associated with a Type-2 immune response for over 150 years in both mice and humans. These crystals, found in parasitic infections and diseases like asthma, can benefit the host during worm infections but also worsen inflammation and mucus production in asthma.

CURRENT OPINION IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Point mutation I634A in the glucocorticoid receptor causes embryonic lethality by reduced ligand binding

Steven Timmermans, Nicolette J. D. Verhoog, Kelly Van Looveren, Sylviane Dewaele, Tino Hochepied, Melanie Eggermont, Barbara Gilbert, Anne Boerema-de Munck, Tineke Vanderhaeghen, Joke Vanden Berghe, Natalia Garcia Gonzalez, Jolien Vandewalle, Yehudi Bloch, Mathias Provost, Savvas N. Savvides, Karolien De Bosscher, Wim Declercq, Robbert J. Rottier, Ann Louw, Claude Libert

Summary: The GR(dim/dim) mice with reduced dimerization propensity have helped define the functions of GR monomers and dimers, while the newly generated GR(D+L/D+L) mice exhibit insufficient ligand binding, leading to perinatal lethality.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Structural basis of cytokine-mediated activation of ALK family receptors

Steven De Munck, Mathias Provost, Michiko Kurikawa, Ikuko Omori, Junko Mukohyama, Jan Felix, Yehudi Bloch, Omar Abdel-Wahab, J. Fernando Bazan, Akihide Yoshimi, Savvas N. Savvides

Summary: ALK and LTK are recently identified receptor tyrosine kinases involved in neural development, cancer, and autoimmune diseases, along with their activating cytokines ALKAL1 and ALKAL2. Structural studies reveal a unique architecture of the cytokine-binding segments, and propose a mechanistic blueprint for the complexes of ALK family receptors.

NATURE (2021)

Article Biochemistry & Molecular Biology

Structural basis of human IL-18 sequestration by the decoy receptor IL-18 binding protein in inflammation and tumor immunity

Sam Detry, Julie Andries, Yehudi Bloch, Cem Gabay, Danielle M. Clancy, Savvas N. Savvides

Summary: In this study, the sequestration mechanism of human IL-18 mediated by IL-18BP was elucidated based on the crystal structure of the IL-18:IL-18BP complex. The detailed structural analysis revealed the interaction landscape and ultra-high affinity of IL-18BP towards IL-18. The study also discovered a novel tetramer assembly, which effectively restrains IL-18 activity. These findings provide insights for structuredriven therapeutic strategies and further functional interrogation of IL-18.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Cell Biology

Structural basis of activation and antagonism of receptor signaling mediated by interleukin-27

Katarzyna Skladanowska, Yehudi Bloch, Jamie Strand, Kerry F. White, Jing Hua, Daniel Aldridge, Martin Welin, Derek T. Logan, Arne Soete, Romain Merceron, Casey Murphy, Mathias Provost, J. Fernando Bazan, Christopher A. Hunter, Jonathan A. Hill, Savvas N. Savvides

Summary: This study presents crystal structures of IL-27 and its receptor, providing insights into their interaction and offering a foundation for further research and therapeutic targeting of IL-27-related diseases.

CELL REPORTS (2022)

Article Ecology

Unexpected complexity of the ammonia monooxygenase in archaea

Logan H. H. Hodgskiss, Michael Melcher, Melina Kerou, Weiqiang Chen, Rafael I. I. Ponce-Toledo, Savvas N. N. Savvides, Stefanie Wienkoop, Markus Hartl, Christa Schleper

Summary: Ammonia oxidation is a critical process in the global nitrogen cycle, but the fundamental knowledge of its key enzyme, the copper-dependent ammonia monooxygenase, is lacking for ammonia-oxidizing archaea (AOA). This study investigates the enzyme's structure in two AOA using blue-native gel electrophoresis and proteomics. Two new protein subunits, AmoY and AmoZ, unique to AOA, were identified, and their genes are linked to other AMO subunit genes in streamlined AOA genomes. These findings provide avenues for further understanding the structure and function of this ecologically important nitrification complex.

ISME JOURNAL (2023)

Review Cell Biology

Pore-forming proteins as drivers of membrane permeabilization in cell death pathways

Peter Vandenabeele, Geert Bultynck, Savvas N. Savvides

Summary: Regulated cell death (RCD) relies on the activation and recruitment of pore-forming proteins (PFPs) to execute specific cell death pathways. This review discusses the structural rearrangements incurred by RCD-related PFPs and describes the mechanisms behind the conversion from an autoinhibited state to a membrane-embedded state. It also highlights the formation and maturation of membrane pores and the implications of different cell death modalities on physiological and pathophysiological processes.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

EGOC inhibits TOROID polymerization by structurally activating TORC1

Manoel Prouteau, Clelia Bourgoint, Jan Felix, Lenny Bonadei, Yashar Sadian, Caroline Gabus, Savvas N. Savvides, Irina Gutsche, Ambroise Desfosses, Robbie Loewith

Summary: Target of rapamycin complex 1 (TORC1) is a protein kinase that regulates cell homeostasis and growth in response to nutrients and stresses. This study found that glucose depletion in Saccharomyces cerevisiae triggers the formation of a large, inactive condensate called TOROID. The researchers demonstrated that the activity of the EGO complex (EGOC) controls the distribution of TOROID, independent of other nutrient-signaling pathways.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2023)

Correction Ecology

Unexpected complexity of the ammonia monooxygenase in archaea (Vol 17, pg 588, 2023)

Logan H. Hodgskiss, Michael Melcher, Melina Kerou, Weiqiang Chen, Rafael I. Ponce-Toledo, Savvas N. Savvides, Stefanie Wienkoop, Markus Hartl, Christa Schleper

ISME JOURNAL (2023)

Article Pharmacology & Pharmacy

Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib

Paola Orlandi, Marta Banchi, Francesca Vaglini, Marco Carli, Stefano Aringhieri, Arianna Bandini, Carla Pardini, Cristina Viaggi, Michele Lai, Greta Ali, Alessandra Ottani, Eleonora Vandini, Patrizia Guidi, Margherita Bernardeschi, Veronica La Rocca, Giulio Francia, Gabriella Fontanini, Mauro Pistello, Giada Frenzilli, Daniela Giuliani, Marco Scarselli, Guido Bocci

Summary: This study investigates the role of MC4R in melanoma and the use of the selective antagonist ML in combination with vemurafenib. The results show that ML can inhibit melanoma cell proliferation and induce apoptosis through the inhibition of ERK1/2 phosphorylation and reduction of BCL-XL expression. The combination of vemurafenib and ML exhibits a synergistic effect in vitro and inhibits tumor growth in vivo without causing adverse effects.

BIOCHEMICAL PHARMACOLOGY (2024)

Article Pharmacology & Pharmacy

Cardiac human bitter taste receptors contain naturally occurring variants that alter function

Conor J. Bloxham, Katina D. Hulme, Fabrizio Fierro, Christian Fercher, Cassandra L. Pegg, Shannon L. O'Brien, Simon R. Foster, Kirsty R. Short, Sebastian G. B. Furness, Melissa E. Reichelt, Masha Y. Niv, Walter G. Thomas

Summary: Bitter taste receptors (T2Rs) are a type of G protein-coupled receptors that allow humans to detect aversive and toxic substances. This study characterized the functional properties of previously identified T2Rs in human cardiac tissues and their naturally occurring polymorphisms. The results showed differences in signaling among different T2R variants, and revealed a potential association between the T2R50 Tyr203 variant and cardiovascular disease.

BIOCHEMICAL PHARMACOLOGY (2024)

Article Pharmacology & Pharmacy

Carfilzomib suppressed LDHA-mediated metabolic reprogramming by targeting ATF3 in esophageal squamous cell carcinoma

Lu Chen, Huanying Shi, Wenxin Zhang, Yongjun Zhu, Haifei Chen, Zimei Wu, Huijie Qi, Jiafeng Liu, Mingkang Zhong, Xiaojin Shi, Tianxiao Wang, Qunyi Li

Summary: This study demonstrates that Carfilzomib exhibits potent anti-tumor activity against esophageal squamous cell carcinoma (ESCC) by triggering mitochondrial apoptosis and reprogramming cellular metabolism. It has been identified that activating transcription factor 3 (ATF3) plays a crucial role as a cellular target in ESCC cells treated with Carfilzomib. Overexpression of ATF3 effectively counteracts the effects of Carfilzomib on ESCC cell proliferation, apoptosis, and metabolic reprogramming. Furthermore, ATF3 mediates the anti-tumor activity of Carfilzomib, suggesting its potential as a therapeutic agent for ESCC.

BIOCHEMICAL PHARMACOLOGY (2024)

Review Pharmacology & Pharmacy

Ferroptosis resistance in cancer: recent advances and future perspectives

Xing Zhang, Xiang Li, Ran Xia, Hong-Sheng Zhang

Summary: This review summarizes recent progress on the mechanisms of ferroptosis resistance in cancer and highlights the role of redox status and metabolism. Combination therapy for ferroptosis has great potential in treating resistant malignant tumors.

BIOCHEMICAL PHARMACOLOGY (2024)